Page 395 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Majestic Announces Financial Results for Q4 2020, FY2020 and Appointment of New Director

First Majestic Announces Financial Results for Q4 2020, FY2020 and Appointment of New Director
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

Yukon territoryUnited statesSanta elenaLa encantadaCoahuila de zaragozaSan dimasKeith neumeyerExchange commissionMichigan technological universityCompany or first majesticToronto stock exchange the companyTonnes milledSustaining costProduction costRealized silver priceOperating earnings

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CD Projekt S A of Class Action Lawsuit and Upcoming Deadline - OTGLF

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CD Projekt S A of Class Action Lawsuit and Upcoming Deadline - OTGLF
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalAdam michal kicinskiLos angelesAbrahaml pomerantzRoberts willoughbyPiotr marcin nielubowiczCd projektUnited states district courtExchange commissionPrnewswire pomerantzSecurities exchangeCompany american depository receiptPomerantz firmCentral district

Gamestop Corporation (NYSE:GME), Nokia Corporation (NYSE:NOK) - SEC Considers Requiring More Transparency From Short Sellers After GameStop Saga: WSJ

The recent frenzied-movements in so-called meme stocks like GameStop Corp (NYSE: GME) are causing the apex market regulator to consider ushering in more .

United statesExchange commissionEntertainment holdings incGamestop corpCitron researchBlackberry ltdWall street journalUnited states securitiesFrank wall streetNokia oyjHoldings incMelvin capitalஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுபொழுதுபோக்கு ஹோல்டிங்ஸ் இன்க்கேம்ஸ்டாப் கார்ப்

Kessler Topaz Meltzer & Check, LLP Files Securities Fraud Class Action Lawsuit Against Exxon Mobil Corporation (NYSE: XOM) With Expanded Class Period

/PRNewswire/ The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a securities fraud class action against Exxon Mobil Corporation.

United statesAdrienne bellJames maro jrJames maroExchange commissionExxon mobil corporationUnited states district courtKessler topaz meltzerMobil corporationNorthern districtDallas divisionBentler actionClass periodPermian basinDelaware basinUnited states securities

Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant Sciences Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids

Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant Sciences Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids •LIBERTY 1 and LIBERTY 2 achieved 73.4% and 71.2% response rates in menstrual blood loss, with an average reduction of 84.3% from baseline •Achieved six of seven key secondary endpoints including reduction of pain •Bone mineral density maintained at levels comparable to placebo •Data were included in U.S. New Drug Application for relugolix combination tablet for uterine fibroids February 17, 2021 20:02 ET | Source: Sumitovant Biopharma Sumitovant Biopharma New York, New York, UNITED STATES New York, London, Feb. 17, 2021 (GLOBE NEWSWIRE) Sumitovant Biopharma Ltd., a majority shareholder of Myovant Sciences (NYSE: MYOV), announced today that the

New yorkUnited statesCity ofUnited kingdomSumitomo dainippon pharmaSumitovant biopharmaMary stutts sumitovant biopharmaMyrtle potterJuan camilo arjona ferreiraMyovant sciences forwardMyovant sciencesDainippon pharmaceutical co ltdAltavant sciencesExchange commissionSpirovant sciencesMyovant sciences inc